PRGO vs RDY Valuation Comparison 2026 — Intrinsic Value Analysis

Quick Summary — RDY scores higher on quality with 9.0/10 vs PRGO's 5.9/10. PRGO trades at $10.46 while RDY trades at $13.03. Both analyzed daily using SEC EDGAR data across 13 institutional models.

PRGO

Drug Manufacturers - Specialty & Generic

Perrigo Company plc

Quality

5.9

out of 10

Value Trap

32

LOW

Price

$10.46

Last close

Models

10/13

Active

VS

RDY

Drug Manufacturers - Specialty & Generic

Dr. Reddy's Laboratories Ltd

Quality

9.0

out of 10

Value Trap

18

SAFE

Price

$13.03

Last close

Models

13/13

Active

PRGO

Markov DDM sees +52.1% upside

Limited to 2/13 visible models

RDY

Quality Score 9.0/10 — top tier

Limited to 2/13 visible models

PRGO vs RDY — Fair Value Comparison

PRGO

RDY

Market Price Model 1 Model 2

Model-by-Model Comparison

Model	Type	PRGO Fair Value	PRGO Upside	RDY Fair Value	RDY Upside
Bayesian DCF	Intrinsic	$2.88	-72.4%	$3.29	-74.8%
Earnings Power Value	Intrinsic	—	—	$7.09	-45.6%
EROIC Spread	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
Markov DDM	Intrinsic	$15.91	+52.1%	$7.80	-40.1%
ML-RIV	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
Dynamic NAV	Asset-Based	$•••.••	••.•%	$•••.••	••.•%
PWERM	Option-Based	$•••.••	••.•%	$•••.••	••.•%
Regime Cross-Sectional	Relative	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%
FTNN Topology	Relative	$•••.••	••.•%	$•••.••	••.•%
RCMH-DCF	Intrinsic	$•••.••	••.•%	$•••.••	••.•%

PRGO vs RDY — Which Stock Is More Undervalued in 2026?

RDY scores higher with a 9.0/10 quality rating vs PRGO's 5.9/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

How Do PRGO and RDY Valuations Compare?

At $10.46, PRGO trades +72.4% above its Bayesian DCF fair value of $2.88, while RDY at $13.03 trades +74.8% above its estimate of $3.29. RDY shows a wider gap between price and intrinsic value.

Quality of Company: PRGO vs RDY

PRGO earns a Quality of Company score of 5.9/10 compared to RDY's 9.0/10. This is a significant quality gap — the higher-scoring company demonstrates materially stronger fundamentals across profitability, growth consistency, and balance sheet health. The QOC score synthesizes 32 signals spanning profitability margins, revenue growth, free cash flow, capital allocation, and leverage.

Value Trap Risk: PRGO vs RDY

PRGO carries a LOW value trap risk (32/100) while RDY shows SAFE risk (18/100). Both companies show manageable value trap risk, suggesting their current valuations are not artificially depressed by fundamental deterioration.

Both in Drug Manufacturers - Specialty & Generic

Both PRGO and RDY operate in Drug Manufacturers - Specialty & Generic, which has 79 stocks tracked by CirclFi. Same-industry comparisons provide the most direct insight into relative valuation since both companies face similar regulatory environments, market dynamics, and competitive pressures. Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN), and ensemble methods (CUCE).

2 of 13 MODELS UNLOCKED

You’re comparing 2 models. 11 more have an opinion.

11 hidden models compare PRGO vs RDY differently — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more. Some may disagree with the 2 you see above.

11 additional fair values per stock Full confidence breakdown Live terminal — 5,000+ stocks

Bloomberg Terminal: ~$2,000/mo · FactSet: ~$1,000/mo · CirclFi: $0.90/day

See All 13 Models — $0.90/day

We don’t predict prices. We show you what 13 independent mathematical frameworks say a stock is worth — and let you decide.

PRGO

View Full Perrigo Company plc Analysis →

RDY

View Full Dr. Reddy's Laboratories Ltd Analysis →

See all Drug Manufacturers - Specialty & Generic stocks →